news
Novel delivery approach demonstrates efficacy of immunotherapy
A first-in-human study showed a novel approach for delivering intrathecal and intravenous immunotherapy improved survival of melanoma patients with leptomeningeal disease (LMD).
List view / Grid view
Bristol-Myers Squibb Foundation
news
Amgen commits $8m to clinical trial diversity programme
The Robert A. Winn Diversity in Clinical Trials Award Program has been pledged $8 million over the next four years by Amgen.
news
Bristol-Myers Squibb Foundation awards nine grants totaling more than $3.5 million to support care for high-risk patients with hepatitis B and C in China and India
4 December 2014 | By Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus (HBV) and hepatitis C virus (HCV) infection by focusing on the most vulnerable, high-risk patient populations...
news
Bristol-Myers Squibb Foundation marks World AIDS Day by awarding $1.47 million in new grants to strengthen HIV-related services in five sub-Saharan countries
2 December 2014 | By The Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation marked World AIDS Day by announcing 12 new grants totaling $1.47 million that focus on strengthening community-based services in sub-Saharan Africa for adolescents and the elderly who are living with HIV and for HIV patients with comorbid female cancers or tuberculosis...
news
XIGDUO™ (dapagliflozin and metformin hydrochloride) approved in the European Union for type 2 diabetes
22 January 2014 | By AstraZeneca
AstraZeneca and Bristol-Myers Squibb announced that Xigduo™ has been granted Marketing Authorisation by the European Commission for the treatment of type 2 diabetes in the European Union...
news
Bristol-Myers Squibb Foundation marks World Diabetes Day with four grants addressing link between diabetes, depression and distress
14 November 2013 | By Bristol-Myers Squibb
“There is a need for the development of short- and long-term diabetes care models and self-management programs..."
news
Bristol-Myers Squibb Foundation, Morehouse School of Medicine partner
10 April 2013 | By Bristol-Myers Squibb Company
Creation of the Morehouse School of Medicine/Bristol-Myers Squibb Foundation Partnership...
news
Five new grants to advance cancer nursing skills in Central and Eastern Europe
11 September 2012 | By Bristol-Myers Squibb Foundation
Recognizing the increasingly important role nurses play...
news
Bristol-Myers Squibb Foundation awards $1.6 million in grants to help communities in India address type 2 diabetes
6 August 2012 | By Bristol-Myers Squibb Company
$1.6 million awarded in grants...
